Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply

Intern Emerg Med. 2021 Jun;16(4):1105-1106. doi: 10.1007/s11739-021-02690-3. Epub 2021 Mar 10.

Authors

Ismael Francisco Aomar-Millán¹, Juan Salvatierra², José Hernández-Quero³

Affiliations

¹ Department of Internal Medicine, San Cecilio University Hospital, Avda. del Conocimiento s/n, 18016, Granada, Spain. iaomarmillan@hotmail.com.
² Department of Rheumatology, San Cecilio University Hospital, Granada, Spain.
³ Department of Infectious Diseases, San Cecilio University Hospital, Granada, Spain.

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Antibodies, Monoclonal, Humanized
COVID-19 Drug Treatment*
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use
Pneumonia* / drug therapy
Retrospective Studies
SARS-CoV-2

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
Interleukin 1 Receptor Antagonist Protein
tocilizumab